John Murphy
About John Murphy
John Murphy serves as the Chief Technology Officer at ONWARD in Lausanne, Switzerland, a position he has held since 2020. He has extensive experience in the medical technology field, having worked in various engineering and leadership roles at companies such as St. Jude Medical, Medtronic, and LivaNova.
Work at Onward
John Murphy has served as the Chief Technology Officer at ONWARD since 2020. His role focuses on leading technological advancements and strategies within the company, which is based in Lausanne, Vaud, Switzerland. His tenure at ONWARD has spanned four years, during which he has contributed to the development of innovative healthcare solutions.
Previous Employment History
Prior to his current position, John Murphy held various roles in prominent medical technology companies. He worked at LivaNova as Chief Technology Officer and Vice President of Research and Development from 2015 to 2020. His experience at St. Jude Medical included positions such as Director of Software and Electrical Engineering and Vice President of Electrical Engineering. He also spent time at Medtronic in multiple managerial roles, focusing on systems and software development.
Education and Expertise
John Murphy earned a Bachelor of Science in Electrical Engineering from the University of North Carolina at Charlotte, completing his studies from 1991 to 1995. He furthered his education at EPFL, where he obtained a Doctor of Philosophy (Ph.D.) in Analytical Design and Optimization of Ultrasonic Vibrational Transducers for Spinal Surgery between 2005 and 2007. His expertise includes developing connected healthcare solutions, algorithm development, and model-based development.
Military Background
Before entering the technology sector, John Murphy served in the U.S. Army as a Sergeant, specializing as a Russian Linguist from 1986 to 1990. This experience provided him with skills that complement his technical career.
Regulatory Experience
John Murphy has significant experience working with U.S. Food and Drug Administration (FDA) regulations, which is critical in the medical technology field. His background also includes strategic organic growth and involvement in mergers and acquisitions activities, enhancing his capability in leading technology initiatives.